Cargando…
Inflammatory Markers Are Not Useful for Identifying Patients With SARS-CoV-2 Infection
Autores principales: | Korley, Frederick K., Nelson, Jacob R., Holmes, Adam R., Hirschl, Jacob R., Sidney, J., Chopra, Perkins Zoey, Medlin, Richard P., Fung, Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729264/ http://dx.doi.org/10.1016/j.jnma.2020.09.035 |
Ejemplares similares
-
RAAS INHIBITORS ARE CARDIOPROTECTIVE IN PATIENTS WITH COVID-19
por: Holmes, Adam R., et al.
Publicado: (2021) -
41 Clinical Outcomes among COVID-19 Patients Taking Non-Steroidal Anti-Inflammatory Drugs
por: Perkins, S.J., et al.
Publicado: (2020) -
296 A Bayesian Approach to Predicting Outcomes During the Initial COVID-19 Outbreak
por: Nelson, J., et al.
Publicado: (2021) -
63 Incidence and Determinants of COVID-19 Emergency Department Revisits
por: Chopra, Z., et al.
Publicado: (2020) -
Interferon-λ3 Exacerbates the Inflammatory Response to Microbial Ligands: Implications for SARS-CoV-2 Pathogenesis
por: Read, Scott A, et al.
Publicado: (2021)